More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

One doctor emphasizes that regardless of the strain of flu, it’s essential to follow the guidelines we used during the ...

While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden ...

Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the ...

The Health Protection Surveillance Centre (HPSC) has reported a further reduction in cases of flu, the Respiratory Syncytial ...

The Cyprus pulmonology society on Thursday urged Health Minister Michael Damianos to approve a respiratory syncytial virus ...

Effective immediately, only two people are permitted at the bedside of patients during the day and one person overnight at ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...

Wales is past the peak of its flu season according to public health bosses. Cases of flu have caused chaos in Wales' ...